CLINICAL_TRIALS
trial_result
· 2018-05-04
Clinical Trial Update: Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer [Phase 3]
Summary
A Phase 3 trial evaluated lamotrigine for chemotherapy-induced peripheral neuropathy in cancer patients, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Neurotoxicity, Pain | Phase 3 | Status: COMPLETED | Results posted: 2018-05-04